Prospective Observational Cohort Registry for Patients With Chronic Myeloid Leukemia at Asan Medical Center
15 Years
N/A
Both
Leukemia, Chronic Myeloid, Myeloid Leukemia, Chronic, Accelerated Phase, Myeloid Leukemia, Chronic, Chronic Phase
Trial Information
Prospective Observational Cohort Registry for Patients With Chronic Myeloid Leukemia at Asan Medical Center
1. Acquisition of informed concent form
2. Data acquisition from medical record including
- demographic / disease-associated factors
- details of treatment, and its results
- complications during treatment
- genetic data
- survival outcome (upto 30 years)
3. Accumulation of data for 30 years
4. Use of data for other retrospective analysis (including Asan Medical center Cell
Banking basic data)
Inclusion Criteria:
- All patients who are diagnosed and/or treated as chronic myeloid leukemia at Asan
Medical Center
- 15 years of age and over
- All patients who give written consent according to guidelines at Asan Medical Center
committee on human research
Exclusion Criteria:
- Patients who refuse to give consent to registering
Type of Study:
Observational [Patient Registry]
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Overall survival
Outcome Time Frame:
30 years
Safety Issue:
No
Principal Investigator
Dae-Young Kim, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Assistant Professor
Authority:
South Korea: Institutional Review Board
Study ID:
AMC-HEMREG-CML
NCT ID:
NCT01761695
Start Date:
January 2013
Completion Date:
December 2047
Related Keywords:
- Leukemia, Chronic Myeloid
- Myeloid Leukemia, Chronic, Accelerated Phase
- Myeloid Leukemia, Chronic, Chronic Phase
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid, Chronic-Phase
- Chronic Disease
Name | Location |
|---|
